Intervention sites | Control sites | Ratio of OR (p value) | |
---|---|---|---|
DVT prophylaxis | |||
OR (95% CI) active-I versus pre-I | 3.38 (1.62 to 7.04) | 0.69 (0.38 to 1.23) | 4.90 (0.0008) |
OR (95% CI) post-I versus pre-I | 1.57 (1.01 to 2.43) | 1.54 (0.88 to 2.69) | 1.02 (0.97) |
Dysphagia | |||
OR (95% CI) active-I versus pre-I | 1.60 (1.15 to 2.22) | 1.54 (1.08 to 2.20) | 1.04 (0.88) |
OR (95% CI) post-I versus pre-I | 1.25 (0.96 to 1.62) | 1.87 (1.40 to 2.49) | 0.67 (0.04) |
Composite indicator | |||
OR (95% CI) active-I versus pre-I | 1.21 (1.05 to 1.39) | 1.05 (0.93 to 1.19) | 1.15 (0.15) |
OR (95% CI) post-I versus pre-I | 1.19 (1.06 to 1.34) | 1.19 (1.08 to 1.32) | 1.00 (0.99) |
Defect-free care | |||
OR (95% CI) active-I versus pre-I | 1.43 (0.89 to 2.31) | 1.14 (0.52 to 2.48) | 1.25 (0.62) |
OR (95% CI) post-I versus pre-I | 1.55 (1.05 to 2.30) | 1.79 (1.00 to 3.24) | 0.87 (0.69) |
Bold values indicate comparisons with p values≤0.05.
Active-I, active-implementation; DVT, deep vein thrombosis; post-I, post-implementation; pre-I, pre-implementation.